Patients with HR/VHR-PCa exhibited significantly shorter time to BCR than low- and intermediate-risk PCa patients (median: 34.7 vs. 53.1 months; p = 0.04) [31]. This evidence concerns the gene BCR and posterior cortical atrophy.